A study has found that a medicines optimisation and patient adherence strategy based on a joint consultant cardiology pharmacist and cardiologist clinic can improve both adherence and outcomes post-MI.
The study involved deployment of a novel joint consultant cardiology pharmacist and cardiologist medicines optimisation clinic was initiated for patients recently discharged following MI.
The study involved the use of a locally developed tool. The ‘My Experience of Taking Medicines’ questionnaire was designed to allow sharing of barriers to adherence with medications. Participants then attended a clinic with the consultant pharmacist or cardiologist (or both). Secondary prevention medicines needs and barriers to adherence were identified and discussed, and an action plan developed.
The study found that levels of medicines optimisation were improved substantially after attendance at the joint clinic. Patient concerns about their medications were significantly decreased as a result of the work. Rates of non-adherence also fell. Readmission rates also declined after the service opened.